Reilly Financial Advisors’s AstraZeneca AZN Stock Holding History

Reilly Financial Advisors’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$1.9M	Sell	16,301 -1,249	-7%	-$147K	0.14%	100
2021 Q3	$2.11M	Sell	17,550 -312	-2%	-$36.3K	0.18%	91
2021 Q2	$2.14M	Buy	17,862 +39	+0.2%	+$4.28K	0.17%	90
2021 Q1	$1.77M	Buy	17,823 +3,141	+21%	+$316K	0.16%	96
2020 Q4	$1.47M	Buy	14,682 +118	+0.8%	+$12.5K	0.14%	100
2020 Q3	$1.6M	Buy	14,564 +2,708	+23%	+$301K	0.17%	87
2020 Q2	$1.25M	Buy	11,856 +11,848	+148,100%	+$1.22M	0.15%	90
2020 Q1	$1K	Sell	8 -65	-89%	-$6.12K	﹤0.01%	825
2019 Q4	$7K	Buy	+73	New	+$6.87K	﹤0.01%	679
2014 Q1	–	Sell	-99	Closed	-$6K	–	795
2013 Q4	$6K	Buy	+99	New	+$5.38K	﹤0.01%	629
2013 Q3	–	Sell	-54	Closed	-$3K	–	743
2013 Q2	$3K	Buy	+54	New	+$2.75K	﹤0.01%	692

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Reilly Financial Advisors's AZN Position: Q4 2021 in Review

Reilly Financial Advisors reduced its AstraZeneca (AZN) stake by 7.1% in Q4 2021, selling an estimated $147K and leaving 16,301 shares worth $1.9M. The position accounts for 0.14% of the portfolio, ranked #100.

Reilly Financial Advisors first reported a position in AZN in Q2 2013 and has held it in 11 quarters since. The position peaked at $2.14M in Q2 2021. 950 funds tracked by Wall St. Rank hold AZN as of Q4 2021.

Reilly Financial Advisors held 16,301 shares of AstraZeneca worth $1.9M as of Q4 2021.
Reilly Financial Advisors sold 1,249 AstraZeneca shares in Q4 2021, an estimated $147K.
AstraZeneca made up 0.14% of Reilly Financial Advisors's portfolio in Q4 2021, its #100 holding.
Reilly Financial Advisors first reported a position in AstraZeneca in Q2 2013 and has held it in 11 quarters since.
Reilly Financial Advisors's AstraZeneca position peaked at $2.14M in Q2 2021.
950 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2021.

Based on Reilly Financial Advisors's 13F filing for Q4 2021, filed 25 Jan 2022.